HLS Therapeutics Partners with Bayer to Commercialize Verquvo in Canada HLS Therapeutics has entered into an agreement with Bayer to commercialize Verquvo (vericiguat) in Canada, marking HLS’s entry i...
Browsing Tag: VICTORIA Phase III Trial
HLS Therapeutics Partners with Bayer to Commercialize Verquvo in Canada HLS Therapeutics has entered into an agreement with Bayer to commercialize Verquvo (vericiguat) in Canada, marking HLS’s entry i...